Publicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (8)

2024

  1. Beneficial Effect of Fingolimod in a Lafora Disease Mouse Model by Preventing Reactive Astrogliosis-Derived Neuroinflammation and Brain Infiltration of T-lymphocytes

    Molecular Neurobiology, Vol. 61, Núm. 6, pp. 3105-3120

  2. Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs

    International journal of molecular sciences, Vol. 25, Núm. 8

2023

  1. TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy

    Neurobiology of Disease, Vol. 176

2010

  1. The impact of α1-adrenoceptors up-regulation accompanied by the impairment of β-adrenergic vasodilatation in hypertension (The Journal of Pharmacology and Experimental Therapeutics (2009) 328, (982-990))

    Journal of Pharmacology and Experimental Therapeutics

  2. α1-Adrenoceptors in the rat cerebral cortex: New insights into the characterization of α1L- and α1D-adrenoceptors

    European Journal of Pharmacology, Vol. 641, Núm. 1, pp. 41-48

2009

  1. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex

    Journal of Biological Chemistry, Vol. 284, Núm. 13, pp. 8247-8255

  2. Increased endoplasmic reticulum stress and decreased proteasomal function in Lafora disease models lacking the phosphatase laforin

    PLoS ONE, Vol. 4, Núm. 6

  3. The Impact of α1-Adrenoceptors Up-regulation accompanied by the mpairment of β-adrenergic vasodilatation in hypertension

    Journal of Pharmacology and Experimental Therapeutics, Vol. 328, Núm. 3, pp. 982-990